Back to Search
Start Over
Dual-action compounds unleash a one-two punch against tuberculosis.
- Source :
-
Cell chemical biology [Cell Chem Biol] 2024 Apr 18; Vol. 31 (4), pp. 627-629. - Publication Year :
- 2024
-
Abstract
- In this issue of Cell Chemical Biology, Gries et al. <superscript>1</superscript> employ an innovative screening approach to identify anti-tuberculosis compounds with dual modes of action: anti-virulence against the type VII secretion system ESX-1 and enhanced ethionamide efficacy. These compounds hold promise for developing multi-target tuberculosis drugs with potential clinical applications.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2451-9448
- Volume :
- 31
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cell chemical biology
- Publication Type :
- Academic Journal
- Accession number :
- 38640900
- Full Text :
- https://doi.org/10.1016/j.chembiol.2024.03.003